The effect of immune modulators on the oncogenic process: adjuvant effect of Staphylococcus aureus in treating murine leukemia.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000917:Antibody Formation; D002462:Cell Membrane / Q000276:immunology; D007167:Immunotherapy; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007942:Leukemia, Experimental / Q000628:therapy*; D008297:Male; D051379:Mice; D008979:Moloney murine leukemia virus; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D013211:Staphylococcus aureus / Q000276:immunology* / Q000648:ultrastructure; D013997:Time Factors
D000276:Adjuvants, Immunologic; D009607:Nitrosourea Compounds